Taylor R E
Yorkshire Regional Centre for Cancer Treatment, Cookridge Hospital, Leeds, UK.
Clin Oncol (R Coll Radiol). 1997;9(6):381-4. doi: 10.1016/s0936-6555(97)80131-8.
Between 1980 and 1986, 384 children were entered into the UKCCSG First Wilms' Tumour Study (UKW1). For 171 patients receiving abdominal radiotherapy (RT) the early and late toxicity has been analysed. Major early toxicity was significantly more likely with whole abdominal (48%) compared with flank (21%) RT (P = 0.007). An increased risk of major early toxicity, which did not reach statistical significance, was seen with right (20.5%) compared with left (7%) flank RT (P = 0.063) and in those treated with a RT dose of > 20 Gy compared with a dose of < or = 20 Gy (P = 0.103). There were 138 evaluable survivors, with a median follow-up of 127 months. Of these, 33 (23.9%) were reported to have late effects, including 27 musculoskeletal (19.6%), four gastrointestinal (2.9%), and three (of 68 girls) ovarian failure (4.4%). There was no apparent effect of age at diagnosis, RT dose or field size on the risk of developing late effects. The continued surveillance of the long term survivors of Wilms' tumour for the late effects of treatment will be important.
1980年至1986年间,384名儿童进入了英国儿童癌症研究小组的首次肾母细胞瘤研究(UKW1)。对171名接受腹部放疗(RT)的患者的早期和晚期毒性进行了分析。与侧腹放疗(21%)相比,全腹放疗(48%)出现严重早期毒性的可能性显著更高(P = 0.007)。右侧侧腹放疗(20.5%)与左侧侧腹放疗(7%)相比,严重早期毒性风险增加,但未达到统计学意义(P = 0.063);放疗剂量> 20 Gy的患者与剂量≤ 20 Gy的患者相比,严重早期毒性风险增加,也未达到统计学意义(P = 0.103)。有138名可评估的幸存者,中位随访时间为127个月。其中,33名(23.9%)报告有晚期效应,包括27名肌肉骨骼方面的(19.6%)、4名胃肠道方面的(2.9%)以及68名女孩中的3名(4.4%)出现卵巢功能衰竭。诊断时的年龄、放疗剂量或照射野大小对发生晚期效应的风险没有明显影响。对肾母细胞瘤长期幸存者进行持续监测以了解治疗的晚期效应将很重要。